Journal of Cosmetic Dermatology, 23(4), 1145-1158
While weight loss injections are generally safe for most patients, certain individuals with specific cardiac conditions require careful evaluation before initiating therapy, and some may need to avoid these medications
Perspectives and conclusions Tirzepatide has demonstrated marked and dose-dependent reductions in glycemic parameters in patients with T2D that, according to the present study data, surpass the effects of the GLP-1RA dulaglutide and semaglutide (66, 67, 71)
Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives
Temporal relationships between pain, mood and urinary symptoms in urological chronic pelvic pain syndrome: a MAPP network study
Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis